While BACE1 activityand protein levels in the brain tend to increase in late-stage AD, BACE1 activity inthe CSF would stabilize or even decrease, perhaps as a result of a reduction inglobal neuronal function [48]. The gene discussed is BACE1; the disease is Alzheimer disease.